Saint Kitts and Nevis vs Tonga: New cases tested for RR-/MDR-TB

Saint Kitts and Nevis
100.0%
in 2019
Tonga
100.0%
in 2023
Saint Kitts and Nevis rank
1st
Tonga rank
1st

New cases tested for RR-/MDR-TB over time

  • Saint Kitts and Nevis
  • Tonga
020406080100201020162023

How they compare

Saint Kitts and Nevis currently reports 100.0% against 100.0% in Tonga, a difference of 0.0%.

Across all 6 years both countries report, Tonga has been ahead every year.

Saint Kitts and Nevis ranks 1st and Tonga ranks 1st of 192 countries.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Saint Kitts and Nevis or Tonga?
Saint Kitts and Nevis, at 100.0% against 100.0% in Tonga as of 2019.
What is the difference in new cases tested for rr-/mdr-tb between Saint Kitts and Nevis and Tonga?
0.0%, with Saint Kitts and Nevis ahead.
How many years of comparable data are there for Saint Kitts and Nevis and Tonga?
6 years are reported by both, from 2010 to 2019.
How do Saint Kitts and Nevis and Tonga rank globally for new cases tested for rr-/mdr-tb?
Saint Kitts and Nevis ranks 1st and Tonga ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Saint Kitts and Nevis vs Tonga: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 06 September 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/st-kitts-and-nevis/tonga/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/st-kitts-and-nevis/tonga/">Saint Kitts and Nevis vs Tonga: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed